FDA
approval
· 2021-12-17
FDA Approved: TEZSPIRE — Original Application (Amgen Inc)
Summary
The FDA approved Tezspire (tezepelumab-ekko) from Amgen under an original Biologics License Application. It is indicated for severe, uncontrolled asthma in adul…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for TEZSPIRE (TEZEPELUMAB-EKKO)